The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Percent Change from Baseline in Body Weight at Week 72
Timeframe: Baseline and Week 72